Undervalued Dividend Growth Stock of the Week: Bristol-Myers Squibb (BMY)
With a market-smashing yield, inflation-beating dividend growth, and the potential that shares are 7% undervalued, long-term dividend growth investors who lean toward yield and income could have a cheap opportunity on their hands with this stock still down heavily from recent highs.
Read More